SEC FIlings

28 Oct

SEC FIlings

Notice of Effectiveness

November 17, 2022
Posted by Jitendra

28 Oct

SEC FIlings

Prospectus

November 17, 2022
Posted by Jitendra

27 Oct

SEC FIlings

Registration of securities, business combinations – Amendment

November 17, 2022
Posted by Jitendra

26 Oct

SEC FIlings

Registration of securities, business combinations – Amendment

November 17, 2022
Posted by Jitendra

24 Oct

SEC FIlings

Registration of securities, business combinations – Amendment

November 17, 2022
Posted by Jitendra

18 Oct

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

18 Oct

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

18 Oct

SEC FIlings

Registration of securities, business combinations – Amendment

November 17, 2022
Posted by Jitendra

14 Sep

SEC FIlings

Prospectuses and communications, business combinations

November 17, 2022
Posted by Jitendra

14 Sep

SEC FIlings

Current report

November 17, 2022
Posted by Jitendra

Notice of Effectiveness

Prospectus

Registration of securities, business combinations – Amendment

Registration of securities, business combinations – Amendment

Registration of securities, business combinations – Amendment

Prospectuses and communications, business combinations

Current report

Registration of securities, business combinations – Amendment

Prospectuses and communications, business combinations

Current report

Gloperba Launch – Nasdaq-2024

A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain

Gout Awareness Day – May 22

Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis

Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch